健能隆Generon www.generonbiomed.com
生物医药是现代制药产业的重要支柱，健能隆致力于运用现代生物技术，按照国际标准研发创新型生物医药产品，在研产品主要针对尚未解决的医疗难题，如肿瘤、炎症和自身免疫性疾病等。 我们立足于在中国进行新药研发， 并将产品推入国际市场。我们的理想是“以创新为本，做更好的药”。我们的社会责任是“让更多的中国病人，用得上高品质的生物药”。 
自创建以来，公司建立了高效哺乳动物细胞的蛋白表达技术及完整的新药研发技术平台，已开发出多个处在不同研发阶段的创新生物药，并拥有这些产品生产的关键技术及其国内、国际专利。健能隆的独特竞争优势，吸引了国内外具有多年国际新药研发经验的专业技术人才加盟，我们将不懈努力地将健能隆打造成一个在全球现代生物医药领域中具有重要影响力的企业。 
在此，我真诚地感谢所有支持和帮助健能隆的各级领导、朋友和合作伙伴。我们承诺，作为一个正在崛起的生物医药企业，健能隆人坚信自己的理念和追求，将用智慧与汗水，生产出更多造福人类的创新生物药物，实现经济效益和社会效益的最大化。

Generon (Shanghai) Corporation (GC) is a biotech company, located at Zhang-Jiang Hi-Tech Park, Shanghai, China. Our company is focused on developing protein therapeutics to treat human diseases with unmet medical needs. We conduct research and development according to the highest standards and to meet regulatory requirements of SFDA and FDA/EMA. We aim to bring our drugs to both domestic and international markets with our partners, especially to bring patients with more affordable and high-quality bio-medicines. Generon is a young and energetic biotech company consisting of highly motivated entrepreneurs and scientists with expertise covering the new drug discovery and development process and with a passion to 'Innovate for Life'. We have established a number of cutting-edge technology platforms including recombinant protein engineering, high expression of proteins in mammalian cells, and scale-up manufacturing. We have established a pipeline with strong IP protection and with balanced risks for development consisting of bio-better, and bio-innovative products.I would like to sincerely thank our friends and partners for your help and support! And thank our team members for your hard working, dedication and great contributions! Working together, we will bring new medicines to patients.